Nemaura Medical Inc. – NASDAQ:NMRD

Add to watchlist

Market closed

Open in about 13 hours

-100.00%

month

-100.00%

quarter

-100.00%

year

Market Cap	8.07K
Enterprise value	34.05M

P/E	-1.67
EV/Sales	85.71
EV/EBITDA	-4.76
Price/Sales	53.68
Price/Book	-2.16
PEG ratio	0.01
EPS	-0.55

Revenue	N/A
EBITDA	-8.00M
Income	-12.74M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-3370.39%
Oper. margin	-1978.81%
Gross margin	37.77%
EBIT margin	-1978.81%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Nemaura Medical Inc. (NASDAQ:NMRD): Profit margin
Sep 2021	0	-3.49M
Dec 2021	183.62K	-3.43M	-1868.76%
Mar 2022	320.27K	-5.49M	-1714.9%
Mar 2023	-1.55M	-328.48K	21.15%

Nemaura Medical Financials Estimate

Q Y

Nemaura Medical Inc. (NASDAQ:NMRD): Analyst Estimates
2026	3.4M	-8.58M	-252.44%
2027	31.4M	0

Analysts Price target
Financials & Ratios estimates

Nemaura Medical Inc. (NASDAQ:NMRD): Debt to assets
Jun 2022	19715044	23.67M	120.08%
Sep 2022	15902748	24.91M	156.67%
Dec 2022	12961698	22.82M	176.06%
Mar 2023	14563233	26.37M	181.12%

Nemaura Medical Inc. (NASDAQ:NMRD): Cash Flow
Sep 2021	-1.78M	-288.03K	-2.3M
Dec 2021	-877.41K	-193.75K	-2.58M
Mar 2022	-2.15M	-76.47K	-2.94M
Mar 2023	-2.36M	-100.41K	5.35M

Nemaura Medical alternative data

Nemaura Medical Inc. (NASDAQ:NMRD): Employee count
Aug 2023	36
Sep 2023	36
Oct 2023	36
Nov 2023	36
Dec 2023	36
Jan 2024	36
Feb 2024	36
Mar 2024	36
Apr 2024	36
May 2024	36
Jun 2024	36
Jul 2024	36

Nemaura Medical
Hedge Funds Holdings Q1 2023

0.19% -3.18%

of NMRD is owned by hedge funds

6 -7

hedge funds hold NMRD stock

45.22K -766.07K

shares is hold by hedge funds

NMRD hedge funds holdings changes

Nemaura Medical
Insider Trading

Nemaura Medical Inc. (NASDAQ:NMRD): Insider trades (number of shares)
Period	Buy	Sel
Jan 2024	100000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value	Source
Purchase	5 Jan 2024	GHADAR-GHADR ARASH officer: Chief Operating Officer officer: Chief Operating Officer	Common Stock	100,000	$0.14	$14,000

NMRD insider trading transactions

Nemaura Medical
Executives

Insider	Age	Since	Compensation
Mr. Justin James Mclarney (1972) Chief Fin. Officer	53		$124,500
Dr. Dewan Fazlul Hoque Chowdhury Ph.D. (1973) Chairman, Chief Executive Officer & Pres	52		$108,210

Nemaura Medical
Latest News

Wednesday, 3 January 2024
07:00	Important Update on Listing Status and Strategic Direction	globenewswire.com
Wednesday, 13 December 2023
08:00	Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision	globenewswire.com
Tuesday, 21 November 2023
08:30	Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth	globenewswire.com
Friday, 17 November 2023
12:47	Nemaura (NMRD) to Expand in UK With Metabolic Health Program	zacks.com
Tuesday, 14 November 2023
08:00	Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	globenewswire.com
Monday, 13 November 2023
16:14	Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update	globenewswire.com
Tuesday, 26 September 2023
09:50	Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.	globenewswire.com
Monday, 18 September 2023
09:15	Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference	GlobeNewsWire
Wednesday, 13 September 2023
13:05	Best Penny Stocks To Buy Now? 10 Under $1 To Watch	PennyStocks
Wednesday, 23 August 2023
13:32	Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?	Zacks Investment Research
Thursday, 16 February 2023
08:15	Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference	GlobeNewsWire
Wednesday, 11 January 2023
08:00	Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference	GlobeNewsWire
Thursday, 1 December 2022
08:15	Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022	GlobeNewsWire
Friday, 11 November 2022
08:00	Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference	GlobeNewsWire
Tuesday, 6 September 2022
08:30	Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference	GlobeNewsWire
Monday, 15 August 2022
11:17	Nemaura Medical, Inc. (NMRD) Reports Q1 Loss, Lags Revenue Estimates	Zacks Investment Research
Monday, 25 April 2022
08:30	Nemaura Medical to Present at the Planet MicroCap Showcase 2022	GlobeNewsWire
Thursday, 24 March 2022
16:24	Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference	GlobeNewsWire
Thursday, 10 March 2022
09:40	Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market	Seeking Alpha
Friday, 7 January 2022
08:00	Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference	GlobeNewsWire
Wednesday, 3 November 2021
18:51	Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021	GlobeNewsWire
Wednesday, 29 September 2021
08:30	Nemaura Medical Launches Beta Version of Its Metabolic Health Program	GlobeNewsWire
Monday, 27 September 2021
08:49	NMRD Stock: Why It Increased Today	Pulse2
08:00	Nemaura Medical Announces Commercial Agreement with UK Licensee	GlobeNewsWire
Friday, 24 September 2021
08:30	Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function	GlobeNewsWire
Friday, 17 September 2021
09:05	Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board	GlobeNewsWire
Monday, 16 August 2021
08:30	Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Nemaura Medical stock today?

One share of Nemaura Medical stock can currently be purchased for approximately $0.
When is Nemaura Medical's next earnings date?

Unfortunately, Nemaura Medical's (NMRD) next earnings date is currently unknown.
Does Nemaura Medical pay dividends?

No, Nemaura Medical does not pay dividends.
How much money does Nemaura Medical make?

Nemaura Medical has a market capitalization of 8.07K and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 84.71% to 77.04K US dollars.
What is Nemaura Medical's stock symbol?

Nemaura Medical Inc. is traded on the NASDAQ under the ticker symbol "NMRD".
What is Nemaura Medical's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Nemaura Medical?

Shares of Nemaura Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Nemaura Medical's key executives?
Nemaura Medical's management team includes the following people:
- Mr. Justin James Mclarney Chief Fin. Officer(age: 53, pay: $124,500)
- Dr. Dewan Fazlul Hoque Chowdhury Ph.D. Chairman, Chief Executive Officer & Pres(age: 52, pay: $108,210)
How many employees does Nemaura Medical have?

As Jul 2024, Nemaura Medical employs 36 workers.
When Nemaura Medical went public?

Nemaura Medical Inc. is publicly traded company for more then 7 years since IPO on 5 Feb 2018.
What is Nemaura Medical's official website?

The official website for Nemaura Medical is nemauramedical.com.
Where are Nemaura Medical's headquarters?

Nemaura Medical is headquartered at 57 West 57th Street, New York, NY.
How can i contact Nemaura Medical?

Nemaura Medical's mailing address is 57 West 57th Street, New York, NY and company can be reached via phone at +64 6 416 7912.

Nemaura Medical Inc.

nemauramedical.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Devices

Sector:

Healthcare

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

+64 6 416 7912

57 West 57th Street
New York, NY 10019

CIK: 0001602078
ISIN: US6404422080
CUSIP: 640442208